Schedule 13G ownership disclosure
Tonix Pharmaceuticals Holding Corp.
Security class unavailable · CUSIP: 890260201
Event date: 2016-11-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,220,055
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-16-001674
- Form type
- SC 13G
- Filer
- Rosalind Advisors, Inc.
- CIK
- CIK 1622627
- Filed
- Nov 30, 2016
- Reporting period
- Nov 28, 2016
- Description
- Schedule 13G beneficial ownership